Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-12-23 to 2025-01-15
Current total value of award: $128442.7
Description: 4566802446!OCREVUS 300 MG/10 ML VIAL 10ML